Allergy Immunotherapy Drops: Treating the Cause, Not the Symptom

Regular allergy medicine, such as antihistamines, decongestants, and nasal steroid sprays, relieves symptoms temporarily by blocking or calming the body's reaction after an allergen triggers it. The effect lasts hours and disappears once the medication wears off, and it never reduces how allergic you are. Immunotherapy drops work on the immune system itself. By exposing it to small, controlled doses of your allergens under the tongue daily, they gradually retrain the response so you react less strongly over time. This addresses the underlying allergic response rather than masking symptoms. The trade-off is that immunotherapy is slow, taken over years, while regular allergy medicine works in minutes. Many people use symptom medicine for immediate relief while pursuing immunotherapy for longer-term change, and outcomes from immunotherapy vary between individuals.

Immunotherapy drops are not described as a cure, and it is important to be precise about this. What they can do is reduce sensitivity to your specific allergens over time and address the underlying allergic response, which is why immunotherapy is called disease-modifying. After a completed multi-year course, many patients experience lasting improvement, and benefit may persist beyond treatment, but this varies from person to person and is never guaranteed. That is a meaningful difference from symptom medications, which provide only temporary relief, but it is not the same as permanently eliminating allergies for everyone. Realistic expectations matter: immunotherapy aims for durable, meaningful reduction in symptoms and reactivity, evaluated and monitored by a clinician, rather than a guaranteed or permanent cure.

In most cases yes, and it is common to use both, especially early in treatment. Because immunotherapy drops take months to begin reducing symptoms and years to complete, antihistamines and other symptom medications remain useful for relief during that time. The two work through different mechanisms and are generally compatible, though you should always confirm your full medication list with your prescribing clinician, since coordination matters. Over time, as immunotherapy reduces your overall sensitivity, many people find they rely on symptom medications less often, though this varies and is not guaranteed. Using antihistamines for day-to-day comfort while immunotherapy builds longer-term change is a reasonable and frequently recommended approach rather than an either-or choice.

The evidence base for sublingual immunotherapy is substantial for environmental allergies. A widely cited 2013 systematic review published in JAMA examined 63 randomized controlled trials and found moderate-grade evidence that sublingual immunotherapy reduces symptoms of allergic rhinitis and rhinoconjunctivitis, with a number of studies showing meaningful improvement. Professional bodies such as the ACAAI and AAAAI recognize sublingual immunotherapy as a legitimate treatment option. It is worth noting that the FDA-approved evidence is strongest for specific tablet products, while compounded liquid drops are used off-label. The evidence is described as moderate rather than definitive, results vary between individuals, and benefit develops over a multi-year course rather than immediately. A clinician can help interpret what the evidence means for your particular allergies.

Many people do find they rely on antihistamines and other symptom medications less as immunotherapy gradually reduces their overall sensitivity, but this is not guaranteed and the timing varies widely. Because immunotherapy works slowly, symptom medicine usually remains useful throughout the early phase of treatment and often well into it, especially during peak allergy seasons. The goal of immunotherapy is a durable reduction in how strongly you react, which for some people translates into needing less day-to-day medication, while others continue to use symptom relief situationally. Whether and when to reduce any medication is a decision to make with your prescribing clinician based on how you are responding, not something to do on your own. Realistic expectations help: immunotherapy aims for meaningful, lasting improvement, not a guaranteed end to all allergy medicine.